Complete remission of Sweet’s syndrome after azacytidine treatment for concomitant myelodysplastic syndrome
| Autor: | Enrico Lista, Gian Matteo Rigolin, Giulia Daghia, Antonio Cuneo, Francesca Cibien, Olga Sofritti, Roberta Gafà, Sara Martinelli, Genesio Leo, Francesco Cavazzini |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
medicine.medical_specialty Biopsy Malignancy Gastroenterology NO Bone Marrow Azacytidine Sweet’s syndrome Myelodysplastic syndromes Internal medicine medicine Humans Aged Skin Sweet's syndrome Azacytidine Hematology medicine.diagnostic_test business.industry Myelodysplastic syndromes Myeloid leukemia medicine.disease Sweet Syndrome Treatment Outcome Myelodysplastic Syndromes Concomitant Immunology Azacitidine business Complete Hematologic Response Sweet’s syndrome |
| Zdroj: | International Journal of Hematology. 99:663-667 |
| ISSN: | 1865-3774 0925-5710 |
| DOI: | 10.1007/s12185-014-1527-9 |
| Popis: | Sweet's syndrome is a rare condition with potentially disabling implications, characterized by painful skin lesions due to neutrophilic dermal infiltration and systemic inflammatory symptoms. A significant proportion of cases is malignancy associated. Hematologic neoplasms, particularly acute myeloid leukemia and myelodysplastic syndromes, are the most commonly associated malignant conditions. Here, we describe the first case of clinical remission of refractory Sweet's syndrome following hypomethylating therapy with azacytidine in a patient with myelodysplastic syndrome who concurrently obtained a complete hematologic response. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink